Systolic BP variability predicts incident Atrial Fibrillation in middle aged & elderly Dr.Niharika Harsha B14 Oct 2022 8:00 PM ISTA new study found that increased visit-to-visit variability of systolic blood pressure strongly predicts incident atrial fibrillation in the...
Diagnosis of AF with smartwatch health apps challenging in patients with abnormal ECGs Dr. Kamal Kant Kohli14 Oct 2022 7:30 PM ISTNew Smartphone tools can record an electrocardiogram (ECG) strip and make an automated diagnosis. They also overcome limitations of implantable...
Lifelong commitment to controlling BP must for continued CV benefits: JAMA Medha Baranwal14 Oct 2022 11:30 AM ISTUSA: Findings from the Systolic Blood Pressure Intervention Trial (SPRINT) trial have shown that intensive blood pressure (BP) control reduces...
Postoperative aspirin as effective as heparin for VTE prevention after Orthopedic Surgery Dr. Kamal Kant Kohli14 Oct 2022 10:30 AM ISTAs a practice Patients who undergo orthopedic trauma surgery have surgery are given a injectable low-molecular-weight heparin for...
COVID-19 Drug paxlovid may have interaction with commonly prescribed heart medications Dr. Kamal Kant Kohli14 Oct 2022 10:00 AM ISTJACC study points to various drug interactions of COVID drug nirmatrelvir-ritonavir (sold under Paxlovid) with various heart medications
Symptoms, quality of life important to guide treatment for peripheral artery disease Isra Zaman14 Oct 2022 9:15 AM ISTPeripheral artery disease or PAD is the condition of developing narrowed or clogged arteries in the legs. For people who live with the condition,...
Habitual Fish Oil Supplementation increases risk of Atrial Fibrillation Dr.Niharika Harsha B13 Oct 2022 7:30 PM ISTRegular intake of fish oil was associated with an increased risk of incident atrial fibrillation irrespective of the genetic predisposition and...
Sacubitril/Valsartan may reduce mitral regurgitation in HFrEF, eliminating need for interventions Medha Baranwal13 Oct 2022 9:00 AM ISTUSA: The severity of mitral regurgitation (MR) in patients with heart failure with reduced ejection fraction (HFrEF) could be reduced by the use of...
Allopurinol fails to improve CV outcomes in ischemic heart disease patients: ALL-HEART trial Dr.Niharika Harsha B12 Oct 2022 8:30 PM ISTA recent study found that allopurinol did not improve the primary outcomes in cardiovascular patients aged 60 years or older with ischemic heart...
Preeclampsia linked to myocardial injury in patients having noncardiac surgery: PREECLAMPSIA-VISION trial Dr. Kamal Kant Kohli12 Oct 2022 7:30 PM ISTAUSTRALIA: According to a study in the Canadian Journal of Cardiology, preeclampsia poses a risk and is linked to myocardial injury in patients...
Metformin emerges as top repurposed drug candidate for Atrial fibrillation treatment: Cleveland Clinic Researchers Dr. Kamal Kant Kohli12 Oct 2022 1:19 PM ISTThe analysis found metformin targeted 30 genes associated with atrial fibrillation, with direct effects on gene expression for eight. Eight other...
Even lower doses of Sacubitril/valsartan suffice for improving outcomes in patients with HFrEF Jacinthlyn Sylvia12 Oct 2022 11:00 AM ISTAccording to a post hoc analysis of PROVE-HF, patients of heart failure who could not reach target dose of angiotensin receptor/neprilysin inhibitor...
